What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?
Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany. manfred.gerlach@uni-wuerzburg.de.
Manfred
M
Gerlach
Medical Faculty Mannheim, Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
Tobias
T
Banaschewski
Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
David
D
Coghill
Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Luis A
LA
Rohde
Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.
Marcel
M
Romanos
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D015982:Bias; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D015203:Reproducibility of Results; D012196:Review Literature as Topic
D000697:Central Nervous System Stimulants; D008774:Methylphenidate